APA (7th ed.) Citation

R, S., SM, H., RH, A., JM, V., HJ, L., N, M., . . . MA, L. (2023). Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma. British journal of haematology, 202(3), 525. https://doi.org/10.1111/bjh.18885

Chicago Style (17th ed.) Citation

R, Stuver, et al. "Final Results of a Phase II Study of CHOEP Plus Lenalidomide as Initial Therapy for Patients with Stage II-IV Peripheral T-cell Lymphoma." British Journal of Haematology 202, no. 3 (2023): 525. https://doi.org/10.1111/bjh.18885.

MLA (9th ed.) Citation

R, Stuver, et al. "Final Results of a Phase II Study of CHOEP Plus Lenalidomide as Initial Therapy for Patients with Stage II-IV Peripheral T-cell Lymphoma." British Journal of Haematology, vol. 202, no. 3, 2023, p. 525, https://doi.org/10.1111/bjh.18885.